Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
[HTML][HTML] Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
T Pitre, R Van Alstine, G Chick, G Leung, D Mikhail… - Cmaj, 2022 - Can Med Assoc
Background: Randomized trial evidence suggests that some antiviral drugs are effective in
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
Background The combination of sofosbuvir and daclatasvir has shown preliminary efficacy
for hospitalized patients with COVID-19 in four open-label studies with small sample sizes …
for hospitalized patients with COVID-19 in four open-label studies with small sample sizes …
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials
CS Kow, A Javed, D Ramachandram… - Expert Review of Anti …, 2022 - Taylor & Francis
Background Several randomized trials have evaluated the effects of sofosbuvir-based direct-
acting antivirals on the clinical outcomes in patients with COVID-19. Methods A systematic …
acting antivirals on the clinical outcomes in patients with COVID-19. Methods A systematic …
Evidence of the Clinical Efficacy of Antiviral Agents against SARS-CoV-2
A Welman, K Outhoff - … Journal of Pharmaceutical Research and Allied …, 2021 - ijpras.com
The highly transmissible SARS-CoV-2, the virus that causes COVID-19, typically induces
atypical pneumonia in humans by replicating in the lower and upper respiratory tract. It may …
atypical pneumonia in humans by replicating in the lower and upper respiratory tract. It may …
Clinical efficacy of sofosbuvir/daclatasvir in patients with COVID-19: a systematic review and meta-analysis of randomized trials
CK Chen, TS Weng, YH Chen, JH Kao… - Expert Review of …, 2022 - Taylor & Francis
Background This study investigated the clinical efficacy sofosbuvir/daclatasvir (SOF-DCV) in
patients with COVID-19. Research design and methods PubMed, Ovid MEDLINE, Embase …
patients with COVID-19. Research design and methods PubMed, Ovid MEDLINE, Embase …
[HTML][HTML] L'elogio dell'incertezza: una revisione sistematica living per valutare l'efficacia e la sicurezza dei trattamenti farmacologici per pazienti affetti da covid-19
F Cruciani, L Amato, F De Crescenzo… - Recenti Progressi in …, 2021 - recentiprogressi.it
Introduzione. Il SARS-CoV-2 è un coronavirus che causa una malattia che può evolvere in
una polmonite interstiziale potenzialmente letale. A dicembre 2020 in Italia più di 2 milioni di …
una polmonite interstiziale potenzialmente letale. A dicembre 2020 in Italia più di 2 milioni di …